@prefix orcid: <
https://orcid.org/
> .
@prefix this: <
http://purl.org/np/RAMSfjkTpWwI7R0IYJk7gGykfz0prA8a3OX62zSzCSl08
> .
@prefix sub: <
http://purl.org/np/RAMSfjkTpWwI7R0IYJk7gGykfz0prA8a3OX62zSzCSl08#
> .
@prefix np: <
http://www.nanopub.org/nschema#
> .
@prefix rdf: <
http://www.w3.org/1999/02/22-rdf-syntax-ns#
> .
@prefix xsd: <
http://www.w3.org/2001/XMLSchema#
> .
@prefix rdfs: <
http://www.w3.org/2000/01/rdf-schema#
> .
@prefix ns2: <
http://twoc-nlp-database-server-1:8555/solr/predicates/select?q=
> .
@prefix ns1: <
https://uts.nlm.nih.gov/uts/umls/concept/
> .
@prefix prov: <
http://www.w3.org/ns/prov#
> .
@prefix ns3: <
http://twoc-nlp-database-server-1:8555/solr/triples/select?q=
> .
@prefix npx: <
http://purl.org/nanopub/x/
> .
sub:Head
{
this:
np:hasAssertion
sub:assertion
;
np:hasProvenance
sub:provenance
;
np:hasPublicationInfo
sub:pubInfo
;
a
np:Nanopublication
.
}
sub:assertion
{
sub:assertion
prov:wasGeneratedBy
"S&T TWOC project version 1" .
sub:version
prov:value
1 .
rdf:object
ns1:C0001675
"adult" ;
ns1:C0030705
"patients" ;
ns1:C0178602
"dose" ;
ns1:C0205081
"moderate" ;
ns1:C0521093
"confirmed" ;
ns1:C0694627
"moderate" ;
ns1:C0750484
"confirmed" ;
ns1:C0869039
"dose" ;
ns1:C1282910
"superior" ;
ns1:C1513374
"moderate" ;
ns1:C1547226
"moderate" ;
ns1:C1706450
"adult" ;
ns1:C1881878
"moderate" ;
ns1:C4049705
"moderate" ;
ns1:C4049706
"moderate" ;
ns1:C4085643
"moderate" ;
ns1:C4321335
"moderate" ;
ns1:C4722418
"moderate" ;
ns1:C4759845
"moderate" ;
ns1:C4761456
"moderate" ;
ns1:C5201148
"moderate" ;
ns1:C5202574
"moderate" ;
ns1:C5203670
"COVID-19" ;
ns1:C5419624
"severe ARDS" .
rdf:predicate
ns2:TRIPLE_UID:3opcv1ee-TRIPLE-ABSTRACT-2
"be" .
rdf:subject
ns1:C0001554
"administration" ;
ns1:C1533734
"administration" ;
ns1:C2348003
"administration" ;
ns1:C5233847
"dexamethasone 20 mg" .
rdfs:Triple-UID
ns3:TRIPLE_UID:3opcv1ee-TRIPLE-ABSTRACT-2
"3opcv1ee-TRIPLE-ABSTRACT-2" .
rdfs:sentence
rdfs:label
"The primary objective of this study is to test the hypothesis that administration of dexamethasone 20 mg is superior to a 6 mg dose in adult patients with moderate or severe ARDS due to confirmed COVID-19." .
rdfs:triple
rdfs:label
"administration of dexamethasone 20 mg is superior to a 6 mg dose in adult patients with moderate or severe ARDS due to confirmed COVID-19" .
}
sub:provenance
{
sub:assertion
prov:generatedAtTime
"2021-07-25T21:47:19.105355"^^
xsd:dateTime
.
}
sub:pubInfo
{
sub:sig
npx:hasAlgorithm
"RSA" ;
npx:hasPublicKey
"MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB" ;
npx:hasSignature
"L8MnXw5f6DTk9UbJj6Fc7Sae1OE5KuBZS9Jf3nGqobVxPTXKsLZReLCZ7PFDKmvmVBJxwX4gnHp+IHFsZsBH5yYSuvW8yu+JLglNqDBC1ktOhfmT9QxWBCjWd8h/qhjFe3ObY+blaMySfjKWf2zitOMyR9ALK7UlxrxGD+bu9/k=" ;
npx:hasSignatureTarget
this:
.
this:
prov:generatedAtTime
"2021-07-25T21:47:19.105355"^^
xsd:dateTime
;
prov:wasAttributedTo
orcid:0000-0002-8954-0470
.
}